Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CANbridge Pharmaceuticals Inc. ( (HK:1228) ) has shared an update.
CANbridge Pharmaceuticals Inc. announced that all resolutions, except one which was withdrawn, were approved at their Annual General Meeting held on June 27, 2025. The resolutions included re-electing directors, authorizing board remuneration, reappointing the auditor, and granting mandates for share issuance and repurchase. This outcome reflects strong shareholder support and positions the company for continued strategic initiatives in its industry.
More about CANbridge Pharmaceuticals Inc.
CANbridge Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for rare diseases and targeted cancers. The company operates primarily in the pharmaceutical industry, aiming to address unmet medical needs in these specialized markets.
Average Trading Volume: 5,318,857
Technical Sentiment Signal: Buy
Current Market Cap: HK$142.3M
See more data about 1228 stock on TipRanks’ Stock Analysis page.